Summary
The influence of food intake on the pharmacokinetics of chlorambucil (C) and its cytotoxic metabolite, phenylacetic acid mustard (PAM), has been studied in man after oral doses of chlorambucil. The administration of chlorambucil with food resulted in slower absorption than when fasting. However, the area under the plasma concentration-time curve (AUC) was unaffected. The mean ratio AUCPAM/AUCC was 2.8 (range 1.4–7.1) under fasting and 3.3 (range 1.3–7.4) under nonfasting conditions. The metabolite very probably plays an important role in the cytotoxic effects observed after administration of C, since calculations show that a major fraction of the metabolite is eliminated by alkylation reactions.
Similar content being viewed by others
References
McLean A, Woods RL, Catovsky D, Farmer P (1979) Pharmacokinetics and metabolism of chlorambucil in patients with malignant disease. Cancer Treat Rev. 6: 33–42
Alberts DS, Chang SY, Chen HSG, Larcom BJ, Jones SE (1979) Pharmacokinetics and metabolism of chlorambucil in man: a preliminary report. Cancer Treat Rev 6: 9–17
Newell DR, Calvert AH, Harrap KR, McElwain TJ (1983) Studies on the pharmacokinetics of chlorambucil and prednimustine in man. Br J Clin Pharmacol 15: 253–258
Goodman GE, McLean A, Alberts DS, Chang SY (1982) Inhibition of human tumour clonogenicity by chlorambucil and its metabolites. Br J Cancer 45: 621–623
Welling PG (1977) Influence of food and diet on gastro-intestinal drug absorption: a review. J Pharmacokinet Biopharm 5: 291–334
Heading RC, Nimmo J, Prescott LF, Tothill P (1973) The dependence of paracetamol absorption on the rate of gastric emptying. Br J Pharmacol 47: 415–421
Ehrsson H, Eksborg S, Wallin I, Nilsson SO (1980) Degradation of chlorambucil in aqueous solution. J Pharm Sci 69: 1091–1094
Melander A, Danielson K, Hanson A, Rudell B, Scherstén B, Thulin T, Wåhlin E (1977) Enhancement of hydralazine bioavailability by food. Clin Pharmacol Ther 22: 104–107
Ehrsson H, Eksborg S, Wallin I, Marde Y, Joansson B (1980) Determination of chlorambucil in plasma by GLC with selected-ion monitoring. J Pharm Sci 69: 710–712
Ehrsson H, Lönroth U, Wallin I, Ehrnebo M, Nilsson SO (1981) Degradation of chlorambucil in aqueous solution — influence of human albumin binding. J Pharm Pharmacol 33: 313–315
Ace LN, Jaffe JM, Kunka RL (1983) Effect of food and a antacid on quinidine bioavailability. Biopharm Drug Disposit 4: 183–190
McDonald H, Place VA, Falk H, Darken MA (1967) Effect of food on absorption of sulfonamides in man. Chemotherapia 12: 282–285
Kelly MR, Cutler RE, Forrey AW, Kimpel BM (1974) Pharmacokinetics of orally administered furosemide. Clin Pharmacol Ther 15: 178–186
Gibaldi M, Perrier D (1975) Pharmacokinetics, Swarbrick J (ed). Marcel Dekker, New York
McLean A, Newell D, Baker G, Connors T (1980) The metabolism of chlorambucil. Biochem Pharmacol 29: 2039–2047
Godenèche D, Madelmont JC, Moreau MF, Plagne R, Meyniel G (1980) Comparative physico-chemical properties, biological effects, and disposition in mice of four nitrogen mustards. Cancer Chemother Pharmacol 5: 1–9
Jusko WJ (1971) Pharmacodynamics of chemotherapeutic effects: dose — time — response relationships for phase — nonspecific agents. J Pharm Sci 60: 892–895
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ehrsson, H., Wallin, I., Simonsson, B. et al. Effect of food on pharmacokinetics of chlorambucil and its main metabolite, phenylacetic acid mustard. Eur J Clin Pharmacol 27, 111–114 (1984). https://doi.org/10.1007/BF02395216
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02395216